A nurse is providing care to a patient with hepatitis
Monitoring pregnant women closely for signs of fulminant hepatitis.
Administering hepatitis B immunoglobulin (HBIG) to exposed contacts.
Educating the patient about the benefits of hepatitis C vaccine.
Advising the patient to avoid sexual contact until cleared of infection.
Which intervention should the nurse prioritize?
The Correct Answer is A
Choice A rationale:
Fulminant hepatitis is a severe and life-threatening complication of hepatitis E, particularly in pregnant women. It can lead to liver failure, and timely monitoring is crucial to detect any early signs of deterioration in the patient's condition. Pregnant women with hepatitis E require close observation and frequent assessment of liver function to ensure prompt intervention if needed.
Choice B rationale:
Administering hepatitis B immunoglobulin (HBIG) to exposed contacts is not the priority in managing a patient with hepatitis
E. Hepatitis E is caused by a different virus (hepatitis E virus) and is not effectively prevented by hepatitis B immunoglobulin.
Choice C rationale:
Educating the patient about the benefits of hepatitis C vaccine is not relevant to the care of a patient with hepatitis
E. These are two different types of viral hepatitis, caused by distinct viruses (hepatitis C virus and hepatitis E virus), and each requires specific management.
Choice D rationale:
Advising the patient to avoid sexual contact until cleared of infection is important in some cases, but it is not the priority intervention for a patient with hepatitis
E. The primary concern in hepatitis E is monitoring for complications, especially in pregnant women, as discussed in choice A rationale.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is D
Explanation
Choice A rationale:
Elevated HCV RNA levels indicate ongoing active viral replication and are not indicative of an effective response to antiviral therapy. The goal of antiviral therapy is to suppress viral replication, leading to decreased or undetectable HCV RNA levels.
Choice B rationale:
Presence of anti-HCV antibodies is a marker of past or current exposure to hepatitis C virus. While it indicates the client's immune response to the virus, it does not provide information about the effectiveness of antiviral therapy in suppressing viral replication.
Choice C rationale:
Detectable HCV core antigen suggests the presence of the virus but does not provide information about viral replication or the effectiveness of antiviral therapy in reducing viral load.
Choice D rationale:
Undetectable HCV RNA 12 weeks after treatment is considered a sustained virological response (SVR) and indicates an effective response to antiviral therapy. SVR means that the virus is undetectable in the blood even after the completion of treatment, which indicates successful viral clearance.
Correct Answer is A
Explanation
Choice A rationale:
The client's statement, "I will take pegylated interferon-alpha as the antiviral agent," demonstrates understanding of the treatment regimen for chronic hepatitis
D. Pegylated interferon-alpha is the recommended antiviral therapy for chronic hepatitis
D. It helps suppress viral replication and reduce liver inflammation, which is essential in managing the disease. Interferon therapy can be used alone or in combination with antiviral agents like lamivudine or adefovir. However, it is crucial to note that interferon therapy may have side effects, and the client should be educated about them.
Choice B rationale:
"I will use ribavirin to suppress viral replication" is incorrect. Ribavirin is an antiviral agent used for the treatment of hepatitis C but is not typically recommended for hepatitis
D. The primary antiviral therapy for hepatitis D is pegylated interferon-alpha.
Choice C rationale:
"I need to continue the treatment for a shorter duration than hepatitis B or C" is incorrect. The treatment duration for chronic hepatitis D is generally longer than that for hepatitis B or
C. The therapy may last for six months to a year or even longer, depending on the individual response to treatment and the level of liver damage.
Choice D rationale:
"The goal of treatment is to achieve undetectable HDV RNA after the treatment ends" is incorrect. While achieving undetectable HDV RNA is a favorable outcome, it may not always be achievable with current therapies. The primary goal of treatment is to suppress viral replication, reduce liver inflammation, and slow down the progression of liver disease.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.